Cargando…
Crosstalk between RON and androgen receptor signaling in the development of castration resistant prostate cancer
Castrate-resistant prostate cancer (CRPC) is the fatal form of prostate cancer. Although reactivation of androgen receptor (AR) occurs following androgen deprivation, the precise mechanism involved is unclear. Here we show that the receptor tyrosine kinase, RON alters mechanical properties of cells...
Autores principales: | Batth, Izhar, Yun, Huiyoung, Hussain, Suleman, Meng, Peng, Osumulski, Powel, Huang, Tim Hui-Ming, Bedolla, Roble, Profit, Amanda, Reddick, Robert, Kumar, Addanki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924697/ https://www.ncbi.nlm.nih.gov/pubmed/26872377 http://dx.doi.org/10.18632/oncotarget.7287 |
Ejemplares similares
-
Evidence for 2-Methoxyestradiol-Mediated Inhibition of Receptor Tyrosine Kinase RON in the Management of Prostate Cancer
por: Batth, Izhar Singh, et al.
Publicado: (2021) -
BRCA1 Interacting Protein COBRA1 Facilitates Adaptation to Castrate-Resistant Growth Conditions
por: Yun, Huiyoung, et al.
Publicado: (2018) -
Nexrutine and exercise similarly prevent high grade prostate tumors in transgenic mouse model
por: Patel, Darpan I., et al.
Publicado: (2019) -
EGFR transactivates RON to drive oncogenic crosstalk
por: Franco Nitta, Carolina, et al.
Publicado: (2021) -
Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer
por: Obinata, Daisuke, et al.
Publicado: (2017)